National Institute of Public Health and the Environment, the Netherlands Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2005
NCT00225407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

cannabis (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 1)

Marijuana Abuse (Phase 1)

Tachycardia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1